title: Cyclic 3',5'-adenosine monophosphate levels during the developmental cycle of Trypanosoma brucei brucei in the rat.
abstract: Intracellular content of cyclic 3',5'-adenosine monophosphate was determined in several strains of Trypanosoma brucei brucei during their growth in rats. In non-relapsing infections with the cloned monomorphic strain 110M and with the cloned pleomorphic strain YTatl, the amount of cyclic AMP per 10(9) trypanosomes increased from 30 to over 90 pmol as the parasitemia increased from patency to over 10(9) organisms per ml. This increase was not observed during non-relapsing infections with strain 427. During infections with strain YTatl in both immunocompetent and lethally X-irradiated rats, cyclic AMP content of the parasite increased from 20--20 pmol per 10(9) cells early in logarithmic growth to 65--70 pmol per 10(9) cells at peak parasitemia, then decreased as the transition to intermediate and short stumpy forms commenced. At crisis, basal levels were reestablished when log slender forms were the lowest percentage of the total population and intermediate and short stumpy forms predominated, suggesting a correlation between morphologic type and level of cyclic AMP per cell during fluctuations in parasitemia. Increases in intracellular cyclic AMP were measured during in vitro incubation of the parasite in medium containing potential effectors of the trypanosome cyclic AMP system. Sodium fluoride, adenosine and methyl xanthines stimulated increases in cyclic AMP content while isoproterenol, prostaglandin E1, serotonin, histamine and several trypanocidal drugs were ineffective. The results are discussed in terms of the possible regulatory role of cyclic AMP in differentiation of trypanosomes.
mesh_terms: D000241:Adenosine / Q000494:pharmacology; D000818:Animals; D000242:Cyclic AMP / Q000378:metabolism*; D005260:Female; D006790:Host-Parasite Interactions; D007121:Immunocompetence / Q000528:radiation effects; D051381:Rats; D012969:Sodium Fluoride / Q000494:pharmacology; D014346:Trypanosoma brucei brucei / Q000187:drug effects / Q000254:growth & development* / Q000378:metabolism; D014970:Xanthines / Q000494:pharmacology
chemical_list: D014970:Xanthines; C008514:methylxanthine; D012969:Sodium Fluoride; D000242:Cyclic AMP; D000241:Adenosine